Skip to main content

Table 1 Analytic dataset

From: Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data

ID Study Treatment Follow up (weeks) Number patients Mean duration (months) Mean size (cm2) Number healed Evidence format available
16 Duby et al. 1993 [18] 4LB 12 25 20.5 11.9 11 AD
   SSB 12 25 26.7 13.1 10
17 Scriven et al. 1998 [19] 4LB 52 32 13 13.3 17.6 AD
   SSB 52 32 21 8.3 18.24
18 Partsch et al. 2001 [20] 4LB 16 53 1.25 1.5 33 AD
   SSB 16 59 1 1.9 43
19 Ukat et al. 2003 [21] 4LB 12 44 -- 17.7 13 AD
   SSB 12 45 -- 12.2 10
20 Franks et al. 2004 [22] 4LB 24 74 2 5 59 AD
   SSB 24 82 2 3.5 62
21 Junger et al. 2004b [23] SSB 12 60 5.57 5.95 19 AD
   HH 12 61 4.14 5.62 29
22 Kralj et al. 1996 [24] 4LB 24 20 7.9 18.6 7 AD
   Ad hoc: Ba 24 20 6.9 17.2 8
23 Polignano et al. 2004b [25] 4LB 24 39 -- 10.1 29 AD
   ZINC 24 29 -- 9.3 19
24 Wilkinson et al. 1997 [26] 4LB 12 17 -- 11.2 8 AD
   Ad hoc: BHeH 12 18 -- 8.6 8
25 Colgan et al. 1995 [27] 4LB 12 10 9.3 27.5 6 AD
   Ad hoc: BzeaH 12 10 66.5 48.5 7
26 Blecken et al. 2005 [28] 4LB 12 12 -- 50.08 4 AD
   Ad hoc: HV 12 12 -- 48.98 4
27 Moffatt et al. 2008 [29] 4LB 4 42 48.8 5.7 3 AD
   2LB 4 39 46.6 11.8 6
28 Szewczyk et al. 2010 [30] 4LB 12 15 -- 6 9 AD
   2LB 12 16 -- 5.3 10
29 Wong et al. 2012 [31] 4LB 24 107 -- -- 72 AD
   SSB 24 107 -- -- 77
30 Iglesias et al. 2004 [32] 4LB 52 195 3 3.81 107 IPD
   SSB 52 192 3 3.82 86
14 Ashby et al. 2013 [17] 4LB 52 224 12.29 9.30 157 IPD
   HH 52 230 10.82 9.41 163
  1. AD – aggregate-level data; IPD – individual patient data; 4LB, SSB, HH, Zinc paste,2LB and the ad hoc systems Ba, BHeH, BzeaH, HV as described in Additional file 1.